These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 6797270
21. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S, Akaza H, Isaka S, Kanetake H, Kubota Y, Kuroda M, Shinohara N, Shinka T, Tachibana M, Naito S, Hirao Y, BCG Tokyo 172 Strain Study Group. Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576 [Abstract] [Full Text] [Related]
22. Intravesical thiotepa in prevention of recurrence of bladder tumour. Ghosal SK, Sen DK. J Indian Med Assoc; 1980 Nov 01; 75(9):173-4. PubMed ID: 6785360 [No Abstract] [Full Text] [Related]
23. [Chemoprophylaxis with intravesical thiotepa in non-infiltrating bladder tumors]. Lancina Martín J, Monsalve Rodríguez M, Gómez Cisneros S, García Alonso J. Arch Esp Urol; 1986 Sep 01; 39(7):479-83. PubMed ID: 3099658 [No Abstract] [Full Text] [Related]
24. [Intravesical chemotherapy in superficial tumors of the bladder]. Schulman CC. Arch Esp Urol; 1983 Sep 01; 36(1):32-40. PubMed ID: 6409013 [No Abstract] [Full Text] [Related]
25. [Postoperative intravesical installation of tetrahydropyranyl-adriamycin (THP) and cytosine arabinoside (CA) for superficial bladder cancer: clinical results of prophylactic effects on recurrence]. Hashimoto H, Yachiku S, Watabe Y, Niibori D, Yamauchi K, Osanai H, Ohashi K, Wakabayashi A, Fujisawa M. Gan To Kagaku Ryoho; 1994 May 01; 21(6):833-8. PubMed ID: 8185341 [Abstract] [Full Text] [Related]
27. [Clinical-experience with thiotepa in the treatment of bladder cancer]. Gallo FJ, Menéndez-Ondina L, Matallana A, Bonilla JA, Serrano E, Carballido JA, Mendoza A. Actas Urol Esp; 1978 May 01; 2(5):237-40. PubMed ID: 103371 [No Abstract] [Full Text] [Related]
28. [A course of pirarubicin vesical irrigation at thirty mg effectively prevents post-TUR recurrence of superficial bladder cancer]. Kawamura S, Fujioka T, Kubo T, Yoshida I, Takata K. Gan To Kagaku Ryoho; 1996 Mar 01; 23(4):465-70. PubMed ID: 8678499 [Abstract] [Full Text] [Related]
32. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors. Veenema RJ, Dean AL, Uson AC, Roberts M, Longo F. J Urol; 1969 May 01; 101(5):711-5. PubMed ID: 4976352 [No Abstract] [Full Text] [Related]
34. [Comparative study of 62 patients randomly treated with adriamycin or cisplatin as chemoprophylaxis of their superficial bladder carcinoma]. Iborra Juan I, Monrós Lliso JL, Ricós Torrent JV, Mazcuñan Fuentes F, Casanova Ramón-Borja J, Solsona Narbón E. Actas Urol Esp; 1988 May 01; 12(1):20-4. PubMed ID: 3389211 [No Abstract] [Full Text] [Related]
39. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer]. Hofmann W, Langkopf B. Z Urol Nephrol; 1982 Dec 01; 75(12):889-95. PubMed ID: 6819737 [No Abstract] [Full Text] [Related]